Last reviewed · How we verify

NCT07409818

A Novel Classification in Calcific Tendinitis of the Shoulder: Evaluating MRI Localization and Related Treatment Strategies

Recruiting now Last updated 13 February 2026
What this trial tests

trial testing Conservative non-surgical treatment in Calcific Tendinitis of Shoulder in 400 participants. Currently enrolling.

Timeline
2 October 2025
Primary endpoint
1 October 2026
2 October 2026

Quick facts

Lead sponsorKoç University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment400
Start date2 October 2025
Primary completion1 October 2026
Estimated completion2 October 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Koç University

Who can join

Eligibility, any sex, with Calcific Tendinitis of Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Calcific tendinitis of the shoulder is among the frequently encountered shoulder problems. Conservative treatment is often preferred for its management. Persistent pain, impingement symptoms due to large calcific deposits, and extension into the bone are indications for surgical intervention. Although many classification methods for calcific tendinitis have been defined in the literature, none of them is directly related to prognosis, treatment options, or surgical management. The aim of this study is to create a new, easy-to-apply, practical, and treatment-related classification system for calcific tendinitis based on the localization of the deposits on MRI. Furthermore, the aim is to compile the current patient cohort according to this new classification and examine the relationship between the treatment applied and the deposit localization in the proposed classification.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Calcific Tendinitis of Shoulder

Currently open trials in the same condition.

Other Koç University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07409818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing